Literature DB >> 30763510

Lifetime Risk of Stroke and Coronary Heart Disease Deaths According to Blood Pressure Level: EPOCH-JAPAN (Evidence for Cardiovascular Prevention From Observational Cohorts in Japan)

Michihiro Satoh1, Takayoshi Ohkubo2,3, Kei Asayama2,3, Yoshitaka Murakami4, Daisuke Sugiyama5, Michiko Yamada6, Shigeyuki Saitoh7, Kiyomi Sakata8, Fujiko Irie9, Toshimi Sairenchi10, Shizukiyo Ishikawa11, Masahiko Kiyama12, Hirofumi Ohnishi13, Katsuyuki Miura14,15, Yutaka Imai3, Hirotsugu Ueshima14,15, Tomonori Okamura5.   

Abstract

Lifetime risk (LTR) provides an absolute risk assessment during the remainder of one’s life. Few studies have focused on the LTRs of stroke and coronary heart disease (CHD), categorized by fine blood pressure in Asian populations. We aimed to assess it using a large database of a meta-analysis with the individual participant data. The present metaanalysis included 107 737 Japanese (42.4% men; mean age, 55.1 years) from 13 cohorts. During the mean follow-up of 15.2±5.3 years (1 559 136 person-years), 1922 died from stroke and 913 from CHD. We estimated risks after adjusting for competing risk of death other than the outcome of interest. The 10-year risk of stroke and CHD deaths at index age of 35 years was ≤1.9% and ≤0.3%, respectively. The LTRs of stroke death at the index age of 35 years (men/women) were 6.1%/4.8% for optimal, 5.7%/6.3% for normal, and 6.6%/6.0% for high-normal blood pressure groups, and 9.1%/7.9% for grade 1, 14.5%/10.3% for grade 2, and 14.6%/14.3% for grade 3 hypertension groups. The LTRs of CHD death similarly elevated with an increase in blood pressure but were lower (≤7.2%) than those of stroke death. In conclusion, blood pressure was clearly associated with an elevated LTR of stroke or CHD death, although the LTR of CHD death was one-half of that of stroke death in an Asian population. These results would help young people with hypertension to adopt a healthy lifestyle or start antihypertensive therapy early.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  blood pressure; coronary disease; follow-up studies; risk assessment; stroke

Mesh:

Year:  2018        PMID: 30763510     DOI: 10.1161/HYPERTENSIONAHA.118.11635

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

1.  Impact of hypertension stratified by diabetes on the lifetime risk of cardiovascular disease mortality in Japan: a pooled analysis of data from the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan study.

Authors:  Yukiko Imai; Takumi Hirata; Shigeyuki Saitoh; Toshiharu Ninomiya; Yoshihiro Miyamoto; Hirofumi Ohnishi; Yoshitaka Murakami; Hiroyasu Iso; Sachiko Tanaka; Katsuyuki Miura; Akiko Tamakoshi; Michiko Yamada; Masahiko Kiyama; Hirotsugu Ueshima; Shizukiyo Ishikawa; Tomonori Okamura
Journal:  Hypertens Res       Date:  2020-07-03       Impact factor: 3.872

2.  Epidemiological characteristics of elevated blood pressure among middle and high school students aged 12-17 years: a cross-sectional study in Jiangsu Province, China, 2017-2018.

Authors:  Xiyan Zhang; Jie Yang; Yan Wang; Weina Liu; Wenyi Yang; Liuwei Gao; Rainer Schwertz; Andreas Welker; Fengyun Zhang; Yonglin Zhou
Journal:  BMJ Open       Date:  2019-08-24       Impact factor: 2.692

3.  Hypertension Control in Young Population: the Earlier, the Better.

Authors:  Wook Bum Pyun
Journal:  Korean Circ J       Date:  2020-12       Impact factor: 3.243

4.  Effects of socioeconomic status on the control of hypertension in patients <65 and ≥65 years of age in Taiwan: a nationwide cross-sectional study.

Authors:  Sheng-Feng Lin; Tzu-Tung Kuo; W H Pan; Chyi Huey Bai
Journal:  BMJ Open       Date:  2022-02-23       Impact factor: 2.692

5.  Prediction of Lifetime Risk of Cardiovascular Disease Deaths Stratified by Sex in the Japanese Population.

Authors:  Yukiko Imai; Sachiko Mizuno Tanaka; Michihiro Satoh; Takumi Hirata; Yoshitaka Murakami; Katsuyuki Miura; Takashi Waki; Aya Hirata; Toshimi Sairenchi; Fujiko Irie; Mizuki Sata; Toshiharu Ninomiya; Takayoshi Ohkubo; Shizukiyo Ishikawa; Yoshihiro Miyamoto; Hirofumi Ohnishi; Shigeyuki Saitoh; Akiko Tamakoshi; Michiko Yamada; Masahiko Kiyama; Hiroyasu Iso; Kiyomi Sakata; Hideaki Nakagawa; Akira Okayama; Hirotsugu Ueshima; Tomonori Okamura
Journal:  J Am Heart Assoc       Date:  2021-11-30       Impact factor: 6.106

6.  Prospective Associations of Accelerometer-Assessed Physical Activity With Mortality and Incidence of Cardiovascular Disease Among Adults With Hypertension: The UK Biobank Study.

Authors:  Borja Del Pozo Cruz; Matthew Ahmadi; Elif Inan-Eroglu; Bo-Huei Huang; Emmanuel Stamatakis
Journal:  J Am Heart Assoc       Date:  2022-03-05       Impact factor: 6.106

7.  Association of growth hormone receptor gene variant with longevity in men is due to amelioration of increased mortality risk from hypertension.

Authors:  Timothy A Donlon; Randi Chen; Kamal H Masaki; D Craig Willcox; Richard C Allsopp; Bradley J Willcox; Brian J Morris
Journal:  Aging (Albany NY)       Date:  2021-06-01       Impact factor: 5.682

8.  The population attributable risk and clustering of stroke risk factors in different economical regions of China.

Authors:  Shuju Dong; Jinghuan Fang; Yanbo Li; Mengmeng Ma; Ye Hong; Li He
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

9.  A Combination of Blood Pressure and Total Cholesterol Increases the Lifetime Risk of Coronary Heart Disease Mortality: EPOCH-JAPAN.

Authors:  Michihiro Satoh; Takayoshi Ohkubo; Kei Asayama; Yoshitaka Murakami; Daisuke Sugiyama; Takashi Waki; Sachiko Tanaka-Mizuno; Michiko Yamada; Shigeyuki Saitoh; Kiyomi Sakata; Fujiko Irie; Toshimi Sairenchi; Shizukiyo Ishikawa; Masahiko Kiyama; Akira Okayama; Katsuyuki Miura; Yutaka Imai; Hirotsugu Ueshima; Tomonori Okamura
Journal:  J Atheroscler Thromb       Date:  2020-04-08       Impact factor: 4.928

10.  Long Term Prognostic Impact of Sex-specific Longitudinal Changes in Blood Pressure. The EPIC-Norfolk Prospective Population Cohort Study.

Authors:  Tiberiu A Pana; Robert N Luben; Mamas A Mamas; John F Potter; Nicholas J Wareham; Kay-Tee Khaw; Phyo K Myint
Journal:  Eur J Prev Cardiol       Date:  2022-02-19       Impact factor: 7.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.